申请人:Yoshitomi Pharmaceutical Industries, Ltd.
公开号:US04450165A1
公开(公告)日:1984-05-22
A dihydropyridine compound of the formula: ##STR1## or a pharmaceutically acceptable acid addition salt thereof, wherein Het is 5- or 6-membered aromatic heteroaryl, R.sup.1 and R.sup.2 are each lower alkyl, R.sup.3 is lower alkyl, R.sup.4 is hydrogen, lower alkyl or aralkyl, R.sup.5 is lower alkyl or aralkyl, and n is 1 or 2. Such compounds are useful as therapeutic agents for myocardial and cerebral ischemic syndroms and hypertension.
一种二氢吡啶化合物的分子式为:##STR1## 或其药学上可接受的酸盐,其中Het是5-或6-成员芳香杂环烷基,R.sup.1和R.sup.2分别是较低的烷基,R.sup.3是较低的烷基,R.sup.4是氢、较低的烷基或芳基烷基,R.sup.5是较低的烷基或芳基烷基,n为1或2。这些化合物可用作治疗心肌和脑缺血综合征以及高血压的治疗剂。